As someone with family members living with cancer, modern genetic sequencing has been the biggest surprise.
Not that we could sequence tumors, but that we could do so at scale and classify therapies by effectiveness against specific mutations (in general, even ignoring targeted therapies).
Widespread cancer sequencing seems like the missing link to promote better outcomes, particularly in metastatic cases.